Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 180 participants.

Also called NCT07032311

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
SIPPA Solutions INC (from the registry)
Registry
  • NCT NCT07032311
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07032311. Randomized; no masking; primary purpose treatment. Start 2026-08-20 (anticipated); primary completion 2027-10-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk
Acronym
SIPPA-QH_HHC-2
Condition
Liver Disease
Intervention (Device)
Behavioral Treatment
Lead sponsor
SIPPA Solutions INC (class: industry)
Collaborator
New York City Health and Hospitals Corporation (class: other)

Record details

Record id
cardio:ct-nct07032311
Content hash
ae77dcfcb159d36dfa6d4c6517d29d7bd54491162d454bb5058e1c4f7b82940b